These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22099838)

  • 1. Engineering of bone marrow cells with fas-ligand protein-enhances donor-specific tolerance to solid organs.
    Askenasy EM; Shushlav Y; Sun Z; Shirwan H; Yolcu ES; Askenasy N
    Transplant Proc; 2011 Nov; 43(9):3545-8. PubMed ID: 22099838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of chimerism formation and tolerance induction from Fas ligand mutant bone marrow donors after nonmyeloablative conditioning.
    Nusair S; Gincberg G; Almogi-Hazan O; Breuer R; Or R; Wallach-Dayan SB
    Transpl Immunol; 2012 Dec; 27(4):184-8. PubMed ID: 22801052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactions.
    Pearl-Yafe M; Yolcu ES; Stein J; Kaplan O; Yaniv I; Shirwan H; Askenasy N
    Stem Cells; 2007 Jun; 25(6):1448-55. PubMed ID: 17363551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized bone marrow transplantation leads to skin allograft acceptance in nonmyeloablated recipients: comparison of intra-bone marrow and isolated limb perfusion.
    Askenasy N
    Stem Cells; 2002; 20(1):86-93. PubMed ID: 11796926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infusion of Lin- bone marrow cells results in multilineage macrochimerism and skin allograft tolerance in minimally conditioned recipient mice.
    Anam K; Amare MF; Zins SR; Davis TA
    Transpl Immunol; 2010 Oct; 24(1):69-75. PubMed ID: 20950686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac allograft acceptance after localized bone marrow transplantation by isolated limb perfusion in nonmyeloablated recipients.
    Askenasy N; Yolcu ES; Shirwan H; Wang Z; Farkas DL
    Stem Cells; 2003; 21(2):200-7. PubMed ID: 12634416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis.
    Pearl-Yafe M; Yolcu ES; Stein J; Kaplan O; Shirwan H; Yaniv I; Askenasy N
    Exp Hematol; 2007 Oct; 35(10):1601-12. PubMed ID: 17889725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts.
    Li S; Salgar SK; Thanikachalam M; Murdock AD; Gammie JS; Demetris AJ; Zeevi A; Pham SM
    J Surg Res; 2006 Dec; 136(2):238-46. PubMed ID: 17046021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of naïve lymphocytes with fas ligand ex vivo prevents graft-versus-host disease without impairing T cell support of engraftment or graft-versus-tumor activity.
    Askenasy N; Mizrahi K; Ash S; Askenasy EM; Yaniv I; Stein J
    Biol Blood Marrow Transplant; 2013 Feb; 19(2):185-95. PubMed ID: 23078782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nonlethal conditioning approach to achieve engraftment of xenogeneic rat bone marrow in mice and to induce donor-specific tolerance.
    Neipp M; Exner BG; Ildstad ST
    Transplantation; 1998 Oct; 66(8):969-75. PubMed ID: 9808477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts.
    Li H; Inverardi L; Molano RD; Pileggi A; Ricordi C
    Transplantation; 2003 Apr; 75(7):966-70. PubMed ID: 12698081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-myeloablative conditioning is sufficient to induce mixed chimerism and subsequent acceptance of donor specific cardiac and skin grafts.
    Liu C; Zhu P; Saito T; Isaka Y; Nagahara Y; Zhuang J; Li XK
    Int Immunopharmacol; 2013 Jul; 16(3):392-8. PubMed ID: 23428909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The induction of skin xenograft tolerance in rat-to-mouse combination could be affected by DFR mediating cells and antibodies against rat bone marrow cells as well as NK cells in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Eto M; Maeda T; Hiromatsu K; Nomoto K; Kong YY; Nomoto K
    Immunobiology; 1995 Aug; 193(5):420-38. PubMed ID: 8522358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.